Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2004-08-05
Original market date: See footnote 1
2001-12-28
Product name:
CEPTAZ INJECTION - PWS IV 2GM/VIAL
DIN:
02215020 Electronic product monograph is not available
Company:
GLAXOSMITHKLINE INC
800
100 Milverton Drive
Mississauga
Ontario
Canada
L5R 4H1
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
08:12.06.12
Anatomical Therapeutic Chemical (ATC): See footnote 4
J01DD02 CEFTAZIDIME
Active ingredient group (AIG) number:See footnote5
0116900002
Active ingredient(s) | Strength |
---|---|
CEFTAZIDIME | 2 G / VIAL |